Daniel Woolson Biography and Net Worth

Corporate Vice President and General Manager, Infusion Systems of ICU Medical


Mr. Woolson has served as our Corporate Vice President and General Manager, Infusion Systems since February 2017. Prior to ICU Medical, Mr. Woolson held various senior management and consulting roles at Vyaire, BD, CareFusion, Cardinal Health, and McKinsey & Company from 1999 to 2016.

What is Daniel Woolson's net worth?

The estimated net worth of Daniel Woolson is at least $2.37 million as of August 30th, 2024. Mr. Woolson owns 13,107 shares of ICU Medical stock worth more than $2,365,420 as of September 19th. This net worth approximation does not reflect any other assets that Mr. Woolson may own. Learn More about Daniel Woolson's net worth.

How do I contact Daniel Woolson?

The corporate mailing address for Mr. Woolson and other ICU Medical executives is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. ICU Medical can also be reached via phone at (949) 366-2183 and via email at [email protected]. Learn More on Daniel Woolson's contact information.

Has Daniel Woolson been buying or selling shares of ICU Medical?

During the last ninety days, Daniel Woolson has sold $408,376.44 in ICU Medical stock. Most recently, Daniel Woolson sold 2,502 shares of the business's stock in a transaction on Friday, August 30th. The shares were sold at an average price of $163.22, for a transaction totalling $408,376.44. Following the completion of the sale, the vice president now directly owns 13,107 shares of the company's stock, valued at $2,139,324.54. Learn More on Daniel Woolson's trading history.

Who are ICU Medical's active insiders?

ICU Medical's insider roster includes Elisha Finney (Director), Vivek Jain (CEO), George Lopez (Director), Virginia Sanzone (VP), Robert Swinney (Director), Christian Voigtlander (COO), and Daniel Woolson (Corporate Vice President and General Manager, Infusion Systems). Learn More on ICU Medical's active insiders.

Are insiders buying or selling shares of ICU Medical?

In the last year, insiders at the medical instruments supplier sold shares 12 times. They sold a total of 69,382 shares worth more than $8,781,551.66. The most recent insider tranaction occured on September, 3rd when CEO Vivek Jain sold 12,000 shares worth more than $1,961,520.00. Insiders at ICU Medical own 6.7% of the company. Learn More about insider trades at ICU Medical.

Information on this page was last updated on 9/3/2024.

Daniel Woolson Insider Trading History at ICU Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/30/2024Sell2,502$163.22$408,376.4413,107View SEC Filing Icon  
3/15/2024Sell791$98.27$77,731.5713,980View SEC Filing Icon  
12/1/2023Sell1,729$88.03$152,203.879,877View SEC Filing Icon  
2/2/2023Sell1,731$200.00$346,200.009,152View SEC Filing Icon  
5/24/2018Sell1,763$273.67$482,480.21View SEC Filing Icon  
See Full Table

Daniel Woolson Buying and Selling Activity at ICU Medical

This chart shows Daniel Woolson's buying and selling at ICU Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ICU Medical Company Overview

ICU Medical logo
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Read More

Today's Range

Now: $181.27
Low: $177.35
High: $181.64

50 Day Range

MA: $147.81
Low: $119.68
High: $179.51

2 Week Range

Now: $181.27
Low: $78.28
High: $181.87

Volume

246,144 shs

Average Volume

278,130 shs

Market Capitalization

$4.42 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65